These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23398169)
1. Sfrp5 correlates with insulin resistance and oxidative stress. Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169 [TBL] [Abstract][Full Text] [Related]
2. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children. Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290 [TBL] [Abstract][Full Text] [Related]
3. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus. Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377 [TBL] [Abstract][Full Text] [Related]
4. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation. Almario RU; Karakas SE Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371 [TBL] [Abstract][Full Text] [Related]
5. The wingless-related integration site-5a/secreted frizzled-related protein-5 system is dysregulated in human sepsis. Schulte DM; Kragelund D; Müller N; Hagen I; Elke G; Titz A; Schädler D; Schumacher J; Weiler N; Bewig B; Schreiber S; Laudes M Clin Exp Immunol; 2015 Apr; 180(1):90-7. PubMed ID: 25382802 [TBL] [Abstract][Full Text] [Related]
6. Wnt5a: a potential factor linking psoriasis to metabolic complications. Gerdes S; Laudes M; Neumann K; Baurecht H; Mrowietz U Exp Dermatol; 2014 Jun; 23(6):438-40. PubMed ID: 24750404 [TBL] [Abstract][Full Text] [Related]
7. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. Catalán V; Gómez-Ambrosi J; Rodríguez A; Pérez-Hernández AI; Gurbindo J; Ramírez B; Méndez-Giménez L; Rotellar F; Valentí V; Moncada R; Martí P; Sola I; Silva C; Salvador J; Frühbeck G J Clin Endocrinol Metab; 2014 Aug; 99(8):E1407-17. PubMed ID: 24840810 [TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. Schulte DM; Müller N; Neumann K; Oberhäuser F; Faust M; Güdelhöfer H; Brandt B; Krone W; Laudes M PLoS One; 2012; 7(2):e32437. PubMed ID: 22384249 [TBL] [Abstract][Full Text] [Related]
9. Effect of SFRP5 (Secreted Frizzled-Related Protein 5) on the WNT5A (Wingless-Type Family Member 5A)-Induced Endothelial Dysfunction and Its Relevance With Arterial Stiffness in Human Subjects. Cho YK; Kang YM; Lee SE; Lee Y; Seol SM; Lee WJ; Park JY; Jung CH Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1358-1367. PubMed ID: 29674475 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Rezagholizadeh F; Keshavarz SA; Djalali M; Rad EY; Alizadeh S; Javanbakht MH Int J Vitam Nutr Res; 2018 Feb; 88(1-2):73-79. PubMed ID: 30856079 [No Abstract] [Full Text] [Related]
11. Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. Miyoshi T; Doi M; Usui S; Iwamoto M; Kajiya M; Takeda K; Nosaka K; Nakayama R; Okawa K; Takagi W; Nakamura K; Hirohata S; Ito H Atherosclerosis; 2014 Apr; 233(2):454-459. PubMed ID: 24530778 [TBL] [Abstract][Full Text] [Related]
12. Sfrp5/Wnt5a and leptin/adiponectin levels in the serum and the periarterial adipose tissue of patients with peripheral arterial occlusive disease. Wang B; Pan Y; Yang G; Cui Z; Yu W; Liu H; Bai B Clin Biochem; 2021 Jan; 87():46-51. PubMed ID: 33188773 [TBL] [Abstract][Full Text] [Related]
13. Plasma Sfrp5 and adiponectin levels in relation to blood pressure among obese children. Yin C; Chu H; Li H; Xiao Y J Hum Hypertens; 2017 Apr; 31(4):284-291. PubMed ID: 27882931 [TBL] [Abstract][Full Text] [Related]
14. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036 [TBL] [Abstract][Full Text] [Related]
15. Sfrp5 associates with beta-cell function in humans. Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073 [TBL] [Abstract][Full Text] [Related]
16. Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study. Carstensen-Kirberg M; Kannenberg JM; Huth C; Meisinger C; Koenig W; Heier M; Peters A; Rathmann W; Roden M; Herder C; Thorand B Cardiovasc Diabetol; 2017 Aug; 16(1):109. PubMed ID: 28851362 [TBL] [Abstract][Full Text] [Related]
17. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Hu Z; Deng H; Qu H Diabetes Res Clin Pract; 2013 Mar; 99(3):391-5. PubMed ID: 23290274 [TBL] [Abstract][Full Text] [Related]
18. SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children. Tan X; Wang X; Chu H; Liu H; Yi X; Xiao Y Clin Endocrinol (Oxf); 2014 Sep; 81(3):363-9. PubMed ID: 24330025 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant. Shin MJ; Lee JH; Jang Y; Park E; Oh J; Chung JH; Chung N Metabolism; 2006 Jul; 55(7):918-22. PubMed ID: 16784964 [TBL] [Abstract][Full Text] [Related]
20. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]